Vesicare Tablet, Film Coated
Product Images NDC 51248-151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vesicare (NDC 51248-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Solifenacin Succinate (Image 01)

FDA Label Image

Image 02

Image 02
This product is called VESIcare and contains solifenacin succinate. It is a tablet designed to be taken once a day. It is stored at 25°C (77°F) and requires a controlled environment. The box can be registered through a USP-controlled process. The package is manufactured in Ireland and includes a designated area for printing LOT, EXP, and serialization information. Additionally, this product has a phone number for customer assistance.*
FDA Label Image

Image 03

Image 03
This is a label of a medicine. It mentions the name of the product as VESIcare, along with its dosage (once-daily), and the number of tablets (30). The product is manufactured in Ireland, and the label bears a National Drug Code (NDC) of 51248-151-01. The label also lists the active ingredient Solifenacin Succinate to be 10mg per tablet. The text mentions that the area above the perforation is varnish-free for printing of LOT, EXP, and serialization information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.